Facility Design and Engineering

Xellia Pharmaceuticals Officially Opens New Anti-Infective Drug Products Manufacturing Site

August 18, 2021

The Cleveland, Ohio facility will produce critical anti-infective drug products for US hospitals.

Artiva Biotherapeutics Builds New US Cell Therapy R&D and Manufacturing Facility

August 18, 2021

Artiva Biotherapeutics’s new R&D and GMP manufacturing center in San Diego, Calif., for NK cell therapies is expected to open in 2022.

Syngene Expands Microbial and Mammalian Manufacturing Facilities in Bengalaru

August 17, 2021

Syngene’s additions include a new microbial facility and an expanded mammalian facility.

Rentschler Biopharma to Begin Construction of New Multi-Product Commercial Manufacturing Facility

August 13, 2021

Rentschler Biopharma has broken ground nearby its Milford, Mass., site where it will build its new multi-product manufacturing facility for commercial production of complex molecules.

Moderna Plans to Build mRNA Vaccine Manufacturing Facility in Canada

August 12, 2021

Moderna will build an mRNA vaccine manufacturing facility in Canada to provide access to domestically manufactured vaccines against respiratory viruses.

AGC Biologics Acquires Cell and Gene Therapy Commercial Manufacturing Facility

August 09, 2021

AGC Biologics has acquired Novartis’ Longmont, Colorado, manufacturing facility for the commercial production of cell and gene therapies.

BeiGene to Build New Manufacturing and Clinical R&D Facility in New Jersey

August 06, 2021

BeiGene plans to build a new campus for R&D and commercial-scale biopharmaceutical manufacturing in Hopewell, NJ.

Implementing Data Integrity Compliance in a GLP Test Facility

August 02, 2021

Consider how to apply ALCOA+ to a building management system in non-clinical laboratories.

Cytiva and Pall Investing $1.5 Billion into Manufacturing Expansion

July 27, 2021

Cytiva and Pall reinforce recent expansion efforts with a $1.5-billion dollar investment in new manufacturing facilities.

BioNTech to Acquire Kite’s TCR Cell Therapy Platform and Manufacturing Facility

July 21, 2021

BioNTech will acquire a TCR cell therapy R&D platform as well as a manufacturing facility in Gaithersburg, Md., from Kite, a Gilead company.